3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Gynecologic
1
Breast
1
Conditions
Colorectal Neoplasms
77
Pancreatic Neoplasms
56
Stomach Neoplasms
52
Rectal Neoplasms
43
Esophageal Squamous Cell Carcinoma
38
Esophageal Neoplasms
38
Neoplasm Metastasis
25
Colonic Neoplasms
23
Neoplasms
15
Cholangiocarcinoma
13
Liver Neoplasms
10
Gastrointestinal Neoplasms
10
Breast Neoplasms
9
Adenocarcinoma Of Esophagus
9
Carcinoma, Hepatocellular
7
Anus Neoplasms
7
Lung Neoplasms
6
Head and Neck Neoplasms
6
Biliary Tract Neoplasms
6
Ovarian Neoplasms
5
Melanoma
5
Adenocarcinoma
5
Kidney Neoplasms
4
Gastrointestinal Diseases
4
Digestive System Neoplasms
4
Carcinoma, Squamous Cell
4
Carcinoma, Non-Small-Cell Lung
4
Uterine Cervical Neoplasms
3
Sarcoma
3
Lymphoma
3
Interventions
Diathermy
6
Fluorouracil
4
Radiotherapy
3
Melphalan
2
Drug Therapy
2
Capecitabine
2
tislelizumab
1
spartalizumab
1
Radiation
1
Oxaliplatin
1
Mitomycin
1
Leucovorin
1
Immunotherapy
1
Immune Checkpoint Inhibitors
1
Gemcitabine
1
Folfox protocol
1
Floxuridine
1
Cytoreduction Surgical Procedures
1
Control Groups
1
Consolidation Chemotherapy
1
Chemoradiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Hyperthermia
×
Drug Therapy
×
Gastrointestinal
×
Clear all
NCT06831981
2025-02-18
ARO 2024-13
University Hospital Tuebingen
Phase NA
Recruiting
264 enrolled
NCT02353858
2018-02-13
HT01
University Hospital Tuebingen
Phase 2
Completed
78 enrolled